AlphaSimPlex Group’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-7,763
Closed -$221K 175
2021
Q3
$221K Sell
7,763
-11,645
-60% -$355K 0.18% 194
2021
Q2
$585K Sell
19,408
-2,874
-13% -$84.8K 0.29% 145
2021
Q1
$568K Sell
22,282
-4,443
-17% -$114K 0.24% 181
2020
Q4
$656K Sell
26,725
-9,107
-25% -$171K 0.23% 205
2020
Q3
$583K Buy
+35,832
New +$667K 0.27% 167
2019
Q2
Sell
-48,693
Closed -$1.32M 224
2019
Q1
$1.32M Buy
48,693
+9,570
+24% +$321K 0.45% 96
2018
Q4
$1.29M Buy
39,123
+10,970
+39% +$441K 1.17% 43
2018
Q3
$1.31M Buy
28,153
+3,956
+16% +$182K 0.65% 57
2018
Q2
$1.05M Buy
24,197
+8,701
+56% +$417K 0.52% 75
2018
Q1
$862K Buy
+15,496
New +$849K 0.5% 74

Other funds holding MD

AlphaSimPlex Group's MD Position: Q4 2021 in Review

AlphaSimPlex Group sold out of Pediatrix Medical (MD) in Q4 2021, closing a stake of 7,763 shares — an estimated $221K sold.

AlphaSimPlex Group first reported a position in MD in Q1 2018 and held it in 10 quarters. The position peaked at $1.32M in Q1 2019. 204 funds tracked by Wall St. Rank hold MD as of Q4 2021.

  • AlphaSimPlex Group reported no remaining Pediatrix Medical position as of Q4 2021 after selling out during the quarter.
  • AlphaSimPlex Group sold 7,763 Pediatrix Medical shares in Q4 2021, an estimated $221K.
  • AlphaSimPlex Group first reported a position in Pediatrix Medical in Q1 2018 and held it in 10 quarters.
  • AlphaSimPlex Group's Pediatrix Medical position peaked at $1.32M in Q1 2019.
  • 204 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2021.

Based on AlphaSimPlex Group's 13F filing for Q4 2021, filed 10 Feb 2022.